Skip to main content
OpenTrials

Clinical trial condition

Slow Virus Diseases

Explore clinical trials studying Slow Virus Diseases. Study availability and eligibility vary by location and protocol.

2,616 public trials 184 recruiting studies
Refine in advanced search Browse all conditions

Slow Virus Diseases trial results

Completed

The Safety and Effectiveness of HBY 097 Used With or Without AZT in HIV-Infected Patients Who Have Mild or No Symptoms

NCT00002357

Conditions
AIDS-Related Complex, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Los Angeles County - USC Med Ctr Los Angeles, California, United States
  • Stanford Univ School of Medicine Stanford, California, United States
  • Georgetown Univ Med Ctr Washington D.C., District of Columbia, United States
  • Med College of Georgia Augusta, Georgia, United States
View Trial Details
Completed

A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection

NCT00002117

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • Kaiser Foundation Hosp Harbor City, California, United States
  • Kaiser Permanente Med Ctr Los Angeles, California, United States
  • Sharp Rees - Stealy Med Group San Diego, California, United States
  • UCSF - San Francisco Gen Hosp San Francisco, California, United States
View all 24 locations
View Trial Details
Completed

Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection

NCT00002441

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +17 more
Locations
  • Univ of Alabama at Birmingham Birmingham, Alabama, United States
  • Phoenix Body Positive Phoenix, Arizona, United States
  • Arizona Clinical Research Ctr Inc Tucson, Arizona, United States
  • Univ of California / UCI Med Ctr Orange, California, United States
View all 67 locations
View Trial Details
Completed

A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.

NCT00002126

Conditions
Acquired Immunodeficiency Syndrome, Agranulocytosis, Blood-Borne Infections, +21 more
Locations
  • Univ of Alabama at Birmingham / AIDS Outpatient Clinic Birmingham, Alabama, United States
  • Maricopa County Med Ctr Phoenix, Arizona, United States
  • CARE Ctr / UCLA Med Ctr Los Angeles, California, United States
  • UCSF - San Francisco Gen Hosp San Francisco, California, United States
View all 22 locations
View Trial Details

Related conditions